Inventor · disambiguated record
Zhongjiang Jia
Also filed as: JIA ZHONGJIANG
49 granted patents·21 pending applications·366 citations·filing 2015–2025
98Inventor score
Top patents by PatentIndex Score
70 records- 0198US12084443B2Process of preparing a PD-1/PD-L1 inhibitorINCYTE CORP·Filed 2023·Granted Sep 10, 2024·5 cites·9 claims
- 0298US11760756B2Crystalline form of a PD-1/PD-L1 inhibitorINCYTE CORP·Filed 2021·Granted Sep 19, 2023·9 cites·46 claims
- 0398US11753406B2Salts of a PD-1/PD-L1 inhibitorINCYTE CORP·Filed 2020·Granted Sep 12, 2023·9 cites·23 claims
- 0498US11104682B2Salts of TAM inhibitorsINCYTE CORP·Filed 2020·Granted Aug 31, 2021·7 cites·35 claims
- 0598US11066394B2Solid forms of an HPK1 inhibitorINCYTE CORP·Filed 2020·Granted Jul 20, 2021·12 cites·44 claims
- 0698US10611762B2Crystalline forms of a FGFR inhibitor and processes for preparing the sameINCYTE CORP·Filed 2018·Granted Apr 7, 2020·29 cites·67 claims
- 0797US11866451B2Salts and crystalline forms of a PD-1/PD-L1 inhibitorINCYTE CORP·Filed 2020·Granted Jan 9, 2024·7 cites·33 claims
- 0897US11780836B2Process of preparing a PD-1/PD-L1 inhibitorINCYTE CORP·Filed 2021·Granted Oct 10, 2023·8 cites·38 claims
- 0997US11591318B2Bipyrazole derivatives as JAK inhibitorsINCYTE CORP·Filed 2021·Granted Feb 28, 2023·6 cites·19 claims
- 1097US11377446B2Crystalline solid forms of a BET inhibitorINCYTE CORP·Filed 2020·Granted Jul 5, 2022·8 cites·14 claims
- 1197US11001571B2Bipyrazole derivatives as JAK inhibitorsINCYTE CORP·Filed 2019·Granted May 11, 2021·15 cites·16 claims
- 1297US10858372B2Amorphous solid form of a BET protein inhibitorINCYTE CORP·Filed 2019·Granted Dec 8, 2020·10 cites·14 claims
- 1397US10189832B2Crystalline solid forms of a BET inhibitorINCYTE CORP·Filed 2017·Granted Jan 29, 2019·23 cites·38 claims
- 1496US11174257B2Salts of an FGFR inhibitorINCYTE CORP·Filed 2019·Granted Nov 16, 2021·21 cites·13 claims
- 1596US11091480B2Crystalline solid forms of a BET inhibitorINCYTE CORP·Filed 2020·Granted Aug 17, 2021·8 cites·12 claims
- 1696US10626114B2Crystalline solid forms of a BET inhibitorINCYTE CORP·Filed 2018·Granted Apr 21, 2020·15 cites·31 claims
- 1796US10329305B2Amorphous solid form of a BET protein inhibitorINCYTE CORP·Filed 2018·Granted Jun 25, 2019·16 cites·19 claims
- 1895US12030882B2Crystalline solid forms of a bet inhibitorINCYTE CORP·Filed 2022·Granted Jul 9, 2024·3 cites·15 claims
- 1995US12024517B2Salts of an FGFR inhibitorINCYTE CORP·Filed 2021·Granted Jul 2, 2024·3 cites·10 claims
- 2095US11905275B2Bipyrazole derivatives as JAK inhibitorsINCYTE CORP·Filed 2023·Granted Feb 20, 2024·2 cites·29 claims
- 2195US11866434B2Process for making a PD-1/PD-L1 inhibitor and salts and crystalline forms thereofINCYTE CORP·Filed 2021·Granted Jan 9, 2024·7 cites·41 claims
- 2295US11472801B2Crystalline forms of a FGFR inhibitor and processes for preparing the sameINCYTE CORP·Filed 2020·Granted Oct 18, 2022·9 cites·30 claims
- 2394US12071439B2Process and intermediates for preparing a JAK inhibitorINCYTE CORP·Filed 2022·Granted Aug 27, 2024·2 cites·31 claims
- 2494US11084822B2Salts and processes of preparing a PI3K inhibitorINCYTE CORP·Filed 2019·Granted Aug 10, 2021·7 cites·37 claims
- 2594US10723700B2Salts of an LSD1 inhibitorINCYTE CORP·Filed 2019·Granted Jul 28, 2020·7 cites·54 claims
- 2694US10336759B2Salts and processes of preparing a PI3K inhibitorINCYTE CORP·Filed 2016·Granted Jul 2, 2019·18 cites·8 claims
- 2794US9862705B2Salts of a pim kinase inhibitorINCYTE CORP·Filed 2016·Granted Jan 9, 2018·13 cites·12 claims
- 2894US9802957B2Processes of preparing a JAK1 inhibitor and new forms theretoINCYTE CORP·Filed 2015·Granted Oct 31, 2017·28 cites·9 claims
- 2993US11787784B2Solid forms of an HPK1 inhibitorINCYTE CORP·Filed 2021·Granted Oct 17, 2023·2 cites·26 claims
- 3093US10968200B2Salts of an LSD1 inhibitor and processes for preparing the sameINCYTE CORP·Filed 2019·Granted Apr 6, 2021·5 cites·34 claims
- 3193US10633387B2Salts of TAM inhibitorsINCYTE CORP·Filed 2018·Granted Apr 28, 2020·10 cites·23 claims
- 3293US10329255B2Salts of an LSD1 inhibitorINCYTE CORP·Filed 2016·Granted Jun 25, 2019·15 cites·57 claims
- 3392US10450325B2Processes of preparing a JAK1 inhibitor and new forms theretoINCYTE CORP·Filed 2017·Granted Oct 22, 2019·11 cites·13 claims
- 3492US10336728B2Salts of a Pim kinase inhibitorINCYTE CORP·Filed 2017·Granted Jul 2, 2019·7 cites·27 claims
- 3590US12187730B2Salts of TAM inhibitorsINCYTE CORP·Filed 2021·Granted Jan 7, 2025·1 cites·30 claims
- 3689US12173006B2Crystalline forms of a phosphoinositide 3-kinase (PI3K) inhibitorINCYTE CORP·Filed 2021·Granted Dec 24, 2024·1 cites·12 claims
- 3789US12024522B2Salts and processes of preparing a PI3K inhibitorINCYTE CORP·Filed 2021·Granted Jul 2, 2024·1 cites·48 claims
- 3887US12247020B2Bipyrazole derivatives as JAK inhibitorsINCYTE CORP·Filed 2024·Granted Mar 11, 2025·0 cites·20 claims
- 3987US11505540B2Salts of a Pim kinase inhibitorINCYTE CORP·Filed 2021·Granted Nov 22, 2022·1 cites·26 claims
- 4087US11186580B2Crystalline forms of a phosphoinositide 3-kinase (PI3K) inhibitorINCYTE CORP·Filed 2019·Granted Nov 30, 2021·4 cites·31 claims
- 4187US11066387B2Salts of a Pim kinase inhibitorINCYTE CORP·Filed 2019·Granted Jul 20, 2021·1 cites·19 claims
- 4286US12459943B2Crystalline solid forms of a BET inhibitorINCYTE CORP·Filed 2024·Granted Nov 4, 2025·0 cites·17 claims
- 4385US2024376106A1Process of preparing a pd-1/pd-l1 inhibitorINCYTE CORP·Filed 2024·Application pending·0 cites
- 4484US12473286B2Salts of an FGFR inhibitorINCYTE CORP·Filed 2024·Granted Nov 18, 2025·0 cites·18 claims
- 4584US2025019366A1Salts of a pim kinase inhibitorINCYTE CORP·Filed 2024·Application pending·0 cites
- 4683US2025188086A1Salts of tam inhibitorsINCYTE CORP·Filed 2024·Application pending·0 cites
- 4782US2025333416A1Process for making a pd-1/pd-l1 inhibitor and salts and crystalline forms thereofINCYTE CORP·Filed 2025·Application pending·0 cites
- 4881US2023219976A1Amorphous solid form of a bet protein inhibitorINCYTE CORP·Filed 2023·Application pending·0 cites
- 4981US2025270221A1Solid forms of jak inhibitor and process of preparing the sameINCYTE CORP·Filed 2025·Application pending·0 cites
- 5080US12043614B2Salts of a Pim kinase inhibitorINCYTE CORP·Filed 2022·Granted Jul 23, 2024·0 cites·5 claims
Showing the top 50 of 70 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when Zhongjiang Jia files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →